Cardiovascular Agents
Showing 1 - 25 of >10,000
Optimising Cardiovascular Health in Endometrial Cancer Survivors
Recruiting
- Endometrial Cancer
- Cardiovascular Diseases
- Lifestyle modification
- +2 more
-
Manchester, United KingdomSt Mary's Hospital
Mar 11, 2022
Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis
Not yet recruiting
- Erythropoietin Resistant Anemia (EPO Resistant Anemia)
- (no location specified)
Sep 22, 2023
Stomach Tumor, Cardiovascular Diseases, Cerebrovascular Disease Trial in Daegu (Platelet function testing)
Recruiting
- Stomach Neoplasm
- +2 more
- Platelet function testing
-
Daegu, Korea, Republic ofDept. of Surgery, Kyungpook National University Chilgok Hospital
Sep 13, 2022
Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))
Recruiting
- Hyperlipidemias
- Evolocumab
- Statins (Cardiovascular Agents)
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 18, 2022
Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney
Recruiting
- Diabetes Mellitus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Myocardial Infarction Type 2 Trial (Coronary computed tomography angiography, Invasive coronary angiography, Transthoracic
Not yet recruiting
- Myocardial Infarction Type 2
- Coronary computed tomography angiography
- +7 more
- (no location specified)
Jun 15, 2022
Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular Trial in León (Dapagliflozin 10mg Tab, Statins (Cardiovascular
Recruiting
- Stroke, Ischemic
- +3 more
- Dapagliflozin 10mg Tab
- +3 more
-
León, Guanajuato, MexicoHospital General de Zona IMSS 21
Oct 3, 2022
Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)
Active, not recruiting
- Multiple Myeloma
- +19 more
- CYNK-001
-
Denver, Colorado
- +8 more
May 24, 2022
Adverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial Encounter Trial in San Francisco
Completed
- Adverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial Encounter
- Cigarette, NIDA test type with 16.6 mg nicotine
- +8 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 17, 2021
Coronary Heart Disease, Cardiovascular Diseases Trial in London (Isoflurane, Sevoflurane or Desflurane, Propofol)
Unknown status
- Coronary Heart Disease
- Cardiovascular Diseases
- Isoflurane, Sevoflurane or Desflurane
- Propofol
-
London, United Kingdom
- +1 more
Feb 23, 2021
Fatty Acids, Alpha-Linolenic Acid, Docosahexaenoic Acids Trial in Wroclaw (Fatty Acids, Unsaturated, Diagnostic Tests)
Enrolling by invitation
- Fatty Acids
- +7 more
- Fatty Acids, Unsaturated
- Diagnostic Tests
-
Wroclaw, Dolny Slask, Poland
- +2 more
Feb 2, 2021
Pulmonary Embolism Trial in Germany, United States (FlowTriever System, Anticoagulation Agents)
Not yet recruiting
- Pulmonary Embolism
- FlowTriever System
- Anticoagulation Agents
-
Birmingham, Alabama
- +32 more
Sep 20, 2023
Vaso-occlusive Crisis, Sickle Cell Disease, Sickle Cell Anemia in Children Trial in Bani Suwayf, Mecca (Omega 3, Vit D, Zinc
Completed
- Vaso-occlusive Crisis
- +2 more
- Omega 3
- +7 more
-
Banī Suwayf, Egypt
- +3 more
Jan 25, 2021
Ischemic Heart Disease Trial in Rome (Aspirin, Atorvastatin, Perindopril)
Unknown status
- Ischemic Heart Disease
- Aspirin, Atorvastatin, Perindopril
-
Rome, Italy
- +1 more
Nov 1, 2019
Myocardial Infarction, Cardiovascular Disease Trial in Worldwide (Cardiovascular Polypill, Treatment Prevention for Secondary
Completed
- Myocardial Infarction
- Cardiovascular Disease
- Cardiovascular Polypill
- Treatment Prevention for Secondary CV
-
Praha, Praha 10, Czechia
- +112 more
Jun 28, 2022
Diabetic Retinopathy Trial (Simvastatin 40mg, Fenofibrate 200mg, Omega 3 fatty acid)
Unknown status
- Diabetic Retinopathy
- Simvastatin 40mg
- +2 more
- (no location specified)
Jan 15, 2020
Myocardial Infarction, Acute Coronary Syndrome, Inflammation Trial in Finland (Hydroxychloroquine, Placebo)
Completed
- Myocardial Infarction
- +5 more
- Hydroxychloroquine
- Placebo
-
Helsinki, Finland
- +5 more
Jun 6, 2020
Type2 Diabetes, Coronary Heart Disease Trial in Portugal (Exposure to Anti-thrombotic treatment agents and glucose lowering
Active, not recruiting
- Type2 Diabetes Mellitus
- Coronary Heart Disease
- Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
-
Amadora, Lisbon, Portugal
- +11 more
Oct 26, 2021
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))
Active, not recruiting
- Diabetes Mellitus
- +6 more
- Dulaglutide
- +6 more
-
Nagoya-shi, Aichi, Japan
- +43 more
Jan 16, 2023
Standard-of-care Erythropoiesis-stimulating Agents on Forearm
Completed
- Cardiovascular Diseases
- Chronic Kidney Disease
- Darbepoetin Alfa
- +3 more
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Jan 7, 2020
Stroke, Medication Adherence Trial in Kumasi (Polycap)
Not yet recruiting
- Stroke
- Medication Adherence
-
Kumasi, GhanaKwame Nkrumah Institute of Science & Technology
Jul 19, 2023
Erythropoiesis Stimulating Agents for Anemia Management in
Completed
- Anemia of Chronic Kidney Disease
- +2 more
-
Giza, Egyptthe Memorial Souad Kafafi University Hospital
Jan 24, 2023
Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic
Recruiting
- Aortic Stenosis
- +4 more
- Aspirin group
- Non-antithrombotic group
-
Shinjuku, Tokyo, JapanKeio University Hospital
Aug 17, 2023
Categories and Attaining LDL-C Targets in Middle Eastern Adults
Not yet recruiting
- Atherosclerotic Cardiovascular Risk
- Low-density-lipoprotein (LDL) Cholesterol
- (no location specified)
Feb 16, 2023
Anti-HLA Immunization And Immunosuppressive Therapy Management
Active, not recruiting
- Kidney Transplantation
- +3 more
- management of immunosuppressive therapy
-
Nancy, Lorraine, FranceCentral HNF
Mar 24, 2022